Literature DB >> 21532371

Treatment with antidepressants increases insulin-like growth factor-I in cerebrospinal fluid.

Claudia Schilling, Werner F Blum, Isabella Heuser, Georgios Paslakis, Stefan A Wudy, Michael Deuschle.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21532371     DOI： 10.1097/JCP.0b013e3182189d86

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN： 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  9 in total

1.  Central IGF-1 protects against features of cognitive and sensorimotor decline with aging in male mice.

Authors:  Gabriela E Farias Quipildor; Kai Mao; Zunju Hu; Ardijana Novaj; Min-Hui Cui; Maria Gulinello; Craig A Branch; Sriram Gubbi; Khushbu Patel; Douglas R Moellering; Stefano Tarantini; Tamas Kiss; Andriy Yabluchanskiy; Zoltan Ungvari; William E Sonntag; Derek M Huffman
Journal:  Geroscience       Date:  2019-05-10       Impact factor: 7.713

2.  Serum levels of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in children with autism spectrum disorder.

Authors:  Zheng Li; Gui-Yuan Xiao; Chun-Yan He; Xia Liu; Xin Fan; Yan Zhao; Nian-Rong Wang
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2022-02-15

3.  Improved Sleep Quality is Associated with Reductions in Depression and PTSD Arousal Symptoms and Increases in IGF-1 Concentrations.

Authors:  Heather L Rusch; Pedro Guardado; Tristin Baxter; Vincent Mysliwiec; Jessica M Gill
Journal:  J Clin Sleep Med       Date:  2015-06-15       Impact factor: 4.062

Review 4.  Second messenger/signal transduction pathways in major mood disorders: moving from membrane to mechanism of action, part I: major depressive disorder.

Authors:  Mark J Niciu; Dawn F Ionescu; Daniel C Mathews; Erica M Richards; Carlos A Zarate
Journal:  CNS Spectr       Date:  2013-03-05       Impact factor: 3.790

5.  Comparison of Serum VEGF, IGF-1, and HIF-1α Levels in Children with Autism Spectrum Disorder and Healthy Controls.

Authors:  Fulya Şimşek; Ümit Işık; Evrim Aktepe; Faruk Kılıç; Fevziye Burcu Şirin; Mustafa Bozkurt
Journal:  J Autism Dev Disord       Date:  2021-01-03

Review 6.  Insulin-Like Growth Factors in the Pathogenesis of Neurological Diseases in Children.

Authors:  Raili Riikonen
Journal:  Int J Mol Sci       Date:  2017-09-26       Impact factor: 5.923

7.  The Beneficial Impact of Antidepressant Drugs on Prenatal Stress-Evoked Malfunction of the Insulin-Like Growth Factor-1 (IGF-1) Protein Family in the Olfactory Bulbs of Adult Rats.

Authors:  Ewa Trojan; Katarzyna Głombik; Joanna Ślusarczyk; Bogusława Budziszewska; Marta Kubera; Adam Roman; Władysław Lasoń; Agnieszka Basta-Kaim
Journal:  Neurotox Res       Date:  2015-11-26       Impact factor: 3.911

Review 8.  Significantly Higher Peripheral Insulin-Like Growth Factor-1 Levels in Patients With Major Depressive Disorder or Bipolar Disorder Than in Healthy Controls: A Meta-Analysis and Review Under Guideline of PRISMA.

Authors:  Kun-Yu Tu; Ming-Kung Wu; Yen-Wen Chen; Pao-Yen Lin; Hung-Yu Wang; Ching-Kuan Wu; Ping-Tao Tseng
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.889

Review 9.  Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression.

Authors:  Marion J F Levy; Fabien Boulle; Harry W Steinbusch; Daniël L A van den Hove; Gunter Kenis; Laurence Lanfumey
Journal:  Psychopharmacology (Berl)       Date:  2018-06-30       Impact factor: 4.530
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.